NOVAVAX COVID-19 VACCINE 90.4% EFFECTIVE IN CLINICAL TRIAL, COMPANY SAYSOne of the concerns, he noted, is that people who are contaminated with the Delta version appear to bring higher viral loads for longer periods of time, meaning they shed more infection. AS COVID-19 CASES WANE, VACCINE-LAGGING AREAS STILL SEE RISKThe great news, Gottlieb said, is that the vaccines appear to work well against the Delta variation with the mRNA jabs showing about 88% efficiency and the viral vector items revealing 60% efficiency. CLICK HERE FOR COMPLETE CORONAVIRUS COVERAGEThe Delta version, which initially emerged in India, is presently categorized as a variant of interest by the Centers for Disease Control and Prevention (CDC), which unlike the World Health Organization (WHO) has yet to raise its status to a variation of issue.
- Enough fentanyl to kill San Francisco: the new wave of the opioid crisis sweeping California – The Guardian
- Delta variant: We dont know if it causes atypical symptoms like gangrene – Business Insider